United States · 
Who invested in Revel Pharmaceuticals?
Revel Pharmaceuticals's investors include Gaingels.
United States · Venture startup
Who invested in Revel Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$84Kraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $84KOct 2025
- Investors
- 1
The rounds
- Oct 2025
Founders and team
From Revel Pharmaceuticals's own website and the SEC filings it signed: 7 on the team.
- Anika SchmidtTranslational Associate Scientist
- Edwin M. DelgadoResearch Associate
- Liyang HuangAssociate Scientist
- Samantha HedleyAssociate Scientist
- Sien TamSenior Research Associate
- Yun-Hsuan HsuResearch Associate II
- Aaron James CravensExecutive Officer, Directori
On the board, as filediJennifer James CochranPatrick James Burgermeister
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Revel Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Revel Pharmaceuticals
How much has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $84K across 1 round since 2025.
When did Revel Pharmaceuticals last raise?
Revel Pharmaceuticals's most recent round was a Venture of $84K in Oct 2025.
What was Revel Pharmaceuticals's biggest round?
Its most recent round, $84K in Oct 2025, is also its largest on record.
Who backed Revel Pharmaceuticals first?
Revel Pharmaceuticals's first round on record, in Oct 2025, was backed by Gaingels.
What stage is Revel Pharmaceuticals at?
Revel Pharmaceuticals's latest named round is a Venture, in Oct 2025.
Where is Revel Pharmaceuticals based?
Revel Pharmaceuticals is based in the United States.
Companies like Revel Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.